Nishar Dipchand 4/A
4/A · Vir Biotechnology, Inc. · Filed Oct 13, 2020
Insider Transaction Report
Form 4/AAmended
Nishar Dipchand
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-05-21+24,885→ 24,885 totalExercise: $37.06From: 2021-05-21Exp: 2030-05-20→ Common Stock (24,885 underlying)